Effect of Celecoxib on Electrophysiological Property of Cardiac Sodium Channel Nav1.5
SUN Jian-fang1， XU Yi-jia2， WANG Zhan-you1
1. School of Life and Health Sciences， Northeastern University， Shenyang 110169， China; 2. School of Life Sciences and Biopharmaceutical Science， Shenyang Pharmaceutical University， Shenyang 110016， China.
SUN Jian-fang， XU Yi-jia， WANG Zhan-you. Effect of Celecoxib on Electrophysiological Property of Cardiac Sodium Channel Nav1.5[J]. Journal of Northeastern University Natural Science, 2019, 40(3): 452-456.
[1]Flower R J.The development of COX2 inhibitors ［J］.Nature Reviews Drug Discovery，2003，2(3):179-191. [2]Solomon S D，Wittes J，Finn P V，et al.Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials:the cross trial safety analysis ［J］.Circulation，2008，117(16):2104-2113. [3]Park S Y，Kim T H，Kim H I，et al.Celecoxib inhibits Na+ currents in rat dorsal root ganglion neurons ［J］.Brain Research，2007，1148:53-61. [4]Ekberg J，Adams D J.Neuronal voltage-gated sodium channel subtypes:key roles in inflammatory and neuropathic pain ［J］.The International Journal of Biochemistry and Cell Biology，2006，38(12):2005-2010. [5]Payandeh J，Gamal El-Din T M，Scheuer T，et al.Crystal structure of a voltage-gated sodium channel in two potentially inactivated states ［J］.Nature，2012，486(7401):135-139. [6]Clancy C E，Tateyama M，Liu H，et al.Non-equilibrium gating in cardiac Na+ channels:an original mechanism of arrhythmia ［J］.Circulation，2003，107(17):2233-2237. [7]Moreau A，Keller D I，Huang H，et al.Mexiletine differentially restores the trafficking defects caused by two brugada syndrome mutations ［J］.Frontiers in Pharmacology， 2012，3:62. [8]Veldkamp M W，Wilders R，Baartscheer A，et al.Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families ［J］.Circulation Research，2003，92(9):976-983. [9]Probst V，Kyndt F，Potet F，et al.Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease ［J］.Journal of the American College Cardiology， 2003，41(4):643-652. [10]Olson T M，Michels V V，Ballew J D，et al.Sodium channel mutations and susceptibility to heart failure and atrial fibrillation ［J］.JAMA，2005，293(4):447-454. [11]Blechschmidt S，Haufe V，Benndorf K，et al.Voltage-gated Na+ channel transcript patterns in the mammalian heart are species-dependent ［J］.Progress in Biophysics and Molecular Biology，2008，98(2/3):309-318. [12]Liu Z R，Tao J，Dong B Q，et al.Pharmacological kinetics of BmK AS，a sodium channel site 4-specific modulator on Nav1.3 ［J］.Neuroscience Bulletin，2012，28(3):209-221. [13]Weber A，Casini A，Heine A，et al.Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib:new pharmacological opportunities due to related binding site recognition ［J］.Journal of Medicinal Chemistry，2004，47(3):550-557. [14]Krum H，Liew D，Aw J，et al.Cardiovascular effects of selective cyclooxygenase-2 inhibitors ［J］.Expert Review of Cardiovascular Therapy，2004，2(2):265-270. [15]Macías A，Moreno C，Moral-Sanz J，et al.Celecoxib blocks cardiac Kv1.5，Kv4.3 and Kv7.1(KCNQ1)channels:effects on cardiac action potentials ［J］.Journal of Molecular and Cellular Cardiology，2010，49(6):984-992. [16]Frolov R V，Ignatova I I，Singh S.Inhibition of HERG potassium channels by celecoxib and its mechanism ［J］.PLoS One，2011，6(10):e26344. [17]Kim S H，Song S H，Kim S G，et al.Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target ［J］.Journal of Cancer Research and Clinical Oncology，2004，130(9):551-560. [18]Zuo C H，Li Z R，Zhou X，et al.Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice ［J］.Chinese Journal of Cancer，2006，25(4):414-420.
